Anemia prevalence and etiology among women, men, and children in Ethiopia: a study protocol for a national population-based survey.
Tadesse, Amare Worku;
Hemler, Elena C;
Andersen, Christopher;
Passarelli, Simone;
Worku, Alemayehu;
Sudfeld, Christopher R;
Berhane, Yemane;
Fawzi, Wafaie W;
(2019)
Anemia prevalence and etiology among women, men, and children in Ethiopia: a study protocol for a national population-based survey.
BMC Public Health, 19 (1).
1369-.
DOI: https://doi.org/10.1186/s12889-019-7647-7
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
BACKGROUND: Anemia remains a public health challenge in Ethiopia, affecting an estimated 56% of children under age 5 years, 23% of women of reproductive age and 18% of adult men. However, anemia etiology and the relative contribution of underlying risk factors for anemia remains unclear and has hindered implementation of anemia control programs. METHODS/DESIGN: Anemia Etiology in Ethiopia (AnemEE) is a population-based cross-sectional survey of six regions of Ethiopia that includes children, women of reproductive age, and men from regionally representative households. The survey will include detailed assessment of anemia, iron, inflammatory and nutritional biomarkers, diet, comorbidities, and other factors. The objectives of AnemEE are 1) to generate evidence for decision-making on the etiology of anemia in Ethiopia among men, women and children and 2) to simulate the potential effect of iron fortification and other interventions on the prevalence of anemia and risk of iron overload. DISCUSSION: AnemEE will provide the most comprehensive evaluation of anemia etiology in Ethiopia to date due to its detailed assessment of diet, biomarkers, infections and other risk factors in a population-based sample. By generating evidence and simulating potential interventions, AnemEE will inform the development of high-impact anemia control programs and policies. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04002466 . Registered on 28 June 2019. Retrospectively registered.